Clemons M - Search Results

1

Management of the menopause in cancer survivors.

Clemons M, Clamp A, Anderson B. Clemons M, et al. Cancer Treat Rev. 2002 Dec;28(6):321-33. doi: 10.1016/s0305-7372(02)00089-0. Cancer Treat Rev. 2002. PMID: 12470982 Review.

2

Does treatment at the time of locoregional failure of breast cancer alter prognosis?

Clemons M, Hamilton T, Goss P. Clemons M, et al. Cancer Treat Rev. 2001 Apr;27(2):83-97. doi: 10.1053/ctrv.2001.0205. Cancer Treat Rev. 2001. PMID: 11319847 Review.

3

Tamoxifen ("Nolvadex"): a review.

Clemons M, Danson S, Howell A. Clemons M, et al. Cancer Treat Rev. 2002 Aug;28(4):165-80. doi: 10.1016/s0305-7372(02)00036-1. Cancer Treat Rev. 2002. PMID: 12363457 Review.

4

Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies.

Clamp A, Danson S, Clemons M. Clamp A, et al. Among authors: clemons m. Lancet Oncol. 2002 Oct;3(10):611-9. doi: 10.1016/s1470-2045(02)00875-6. Lancet Oncol. 2002. PMID: 12372723 Review.

5

Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?

Clemons M, Coleman RE, Verma S. Clemons M, et al. Cancer Treat Rev. 2004 Jun;30(4):325-32. doi: 10.1016/j.ctrv.2004.03.004. Cancer Treat Rev. 2004. PMID: 15145507 Review.

6

Assessment of therapeutic response in patients with metastatic bone disease.

Clamp A, Danson S, Nguyen H, Cole D, Clemons M. Clamp A, et al. Among authors: clemons m. Lancet Oncol. 2004 Oct;5(10):607-16. doi: 10.1016/S1470-2045(04)01596-7. Lancet Oncol. 2004. PMID: 15465464 Review.

7

Hormonal and genetic risk factors for breast cancer.

Clamp A, Danson S, Clemons M. Clamp A, et al. Among authors: clemons m. Surgeon. 2003 Feb;1(1):23-31. doi: 10.1016/s1479-666x(03)80005-7. Surgeon. 2003. PMID: 15568421 Review.

8

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

Freedman OC, Verma S, Clemons MJ. Freedman OC, et al. Among authors: clemons mj. Cancer Treat Rev. 2005 Feb;31(1):1-17. doi: 10.1016/j.ctrv.2004.09.008. Epub 2004 Nov 18. Cancer Treat Rev. 2005. PMID: 15707700 Review.

9

Should oral bisphosphonates be standard of care in women with early breast cancer?

Clemons M, Verma S. Clemons M, et al. Breast Cancer Res Treat. 2005 Apr;90(3):315-8. doi: 10.1007/s10549-004-4259-3. Breast Cancer Res Treat. 2005. PMID: 15830146 Review.

10

Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: a systematic review.

Trudeau M, Sinclair SE, Clemons M; Breast Cancer Disease Site Group. Trudeau M, et al. Among authors: clemons m. Cancer Treat Rev. 2005 Jun;31(4):283-302. doi: 10.1016/j.ctrv.2005.03.007. Cancer Treat Rev. 2005. PMID: 15916855 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters